NeuralPlatform
NeuralPlatform Raises $100M Growth to Transform Biotech
Quick Facts
NeuralPlatform Raises $100M Growth in Latest Funding Round
NeuralPlatform has successfully closed a $100M Growth funding round, marking a significant milestone in the company's growth trajectory. The round was led by Index Ventures, with participation from Y Combinator.
Company Overview
Founded in 2021 and headquartered in Austin, TX, NeuralPlatform has established itself in the Biotech space. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses
With a current valuation of $15B, the company has demonstrated strong market traction and investor confidence.
Investment Details
- Amount Raised: $100M Growth
- Valuation: $15B
- Lead Investor: Index Ventures
Future Outlook
As NeuralPlatform moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the biotech space.
Key Investors
About the Author
Related Company Reports
PrimeNet Raises $300M Series C to Transform Biotech
PrimeNet has secured $300M Series C in funding to accelerate growth and innovation. Leading machine learning platform automating enterprise workflows with advanced AI models...
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...